[1]
Kaghazian, H. et al. 2023. ANIMAL PRE-CLINICAL STUDY OF AN INACTIVATED SARSCoV-2 VACCINE CANDIDATE (OSVID-19 ®): IMMUNOGENICITY, PROTECTIVE, AND SAFETY ASPECTS. Journal of Population Therapeutics and Clinical Pharmacology. 30, 17 (Jul. 2023), 333–353. DOI:https://doi.org/10.53555/jptcp.v30i17.1555.